Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Amanda Dittmer

Nurse Practitioner, Psychiatric/Mental Health Port Charlotte, FL Nurse Practitioner

NPI 1134572274 CMS profile 11150318

3191 Harbor Blvd Ste B, Port Charlotte, FL 33952

Open in the dashboard

General payments

$15,474

831 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amanda Dittmer of Port Charlotte, FL is reported in the CMS Open Payments database as having received $15,474 across 831 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,073 222
2024 General $2,807 153
2023 General $3,396 179
2022 General $3,212 165
2021 General $1,986 112

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amanda Dittmer
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Amanda Dittmer were reported at $4,073. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Amanda Dittmer Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,986 $166 $54–$482 $132
2022 $3,212 $195 $66–$559 $149
2023 $3,396 $233 $82–$673 $160
2024 $2,807 $236 $84–$688 $164
2025 $4,073 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Vanda Pharmaceuticals Inc. $1,358 49 payments
  2. AbbVie, Inc. $1,282 89 payments
  3. Otsuka America Pharmaceutical, Inc. $1,269 68 payments
  4. Alkermes, Inc. $1,145 62 payments
  5. Janssen Pharmaceuticals, Inc $1,134 39 payments
  6. Lundbeck LLC $1,114 49 payments
  7. ITI, Inc. $1,108 90 payments
  8. Corium, Inc. $991 60 payments
  9. Neurocrine Biosciences, Inc. $806 33 payments
  10. Ironshore Pharmaceuticals Inc. $601 35 payments
  11. Other $4,665 257 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $15,474 831 payments
Products named General payments · program years 2021–2025
  1. FANAPT $1,358 49 payments
  2. HETLIOZ $1,159 42 payments
  3. INVEGA TRINZA $1,070 36 payments
  4. VRAYLAR $1,046 69 payments
  5. ARISTADA Cns $1,041 55 payments
  6. ARISTADA Cns $1,041 55 payments
  7. INVEGA SUSTENNA $1,040 35 payments
  8. REXULTI Psychiatry $1,009 44 payments
  9. Azstarys $968 58 payments
  10. REXULTI Psychiatry $953 47 payments
  11. Other $11,980 688 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

831 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Psychiatric/Mental Health in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record